241 related articles for article (PubMed ID: 12930695)
1. [Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
Nie GH; Lu YD
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1356-8. PubMed ID: 12930695
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
4. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
6. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
8. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
9. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
10. Vestibular and audiologic functions in gentamicin-treated Menière's disease.
Möller C; Odkvist LM; Thell J; Larsby B; Hydén D
Am J Otol; 1988 Sep; 9(5):383-91. PubMed ID: 3202127
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
Suryanarayanan R; Cook JA
J Laryngol Otol; 2004 Jul; 118(7):489-95. PubMed ID: 15318953
[TBL] [Abstract][Full Text] [Related]
13. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
Kaplan DM; Hehar SS; Bance ML; Rutka JA
Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
[TBL] [Abstract][Full Text] [Related]
14. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
16. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
[TBL] [Abstract][Full Text] [Related]
17. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic gentamicin therapy for intractable Ménière's disease.
De Beer L; Stokroos R; Kingma H
Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
Helling K; Schönfeld U; Clarke AH
Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
[TBL] [Abstract][Full Text] [Related]
20. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
